Magellan Health Inc  

(Public, NASDAQ:MGLN)   Watch this stock  
Find more results for MGLN
+0.46 (0.77%)
Real-time:   1:08PM EST
NASDAQ real-time data - Disclaimer
Currency in USD
Range 59.35 - 60.14
52 week 52.37 - 63.81
Open 59.59
Vol / Avg. 66,012.00/163,387.00
Mkt cap 1.64B
P/E 21.74
Div/yield     -
EPS 2.75
Shares 27.65M
Beta 0.67
Inst. own 94%
Feb 26, 2015
Q4 2014 Magellan Health Inc Earnings Call - 10:00AM EST - Add to calendar
Feb 26, 2015
Q4 2014 Magellan Health Inc Earnings Release - 9:30AM EST - Add to calendar
Jan 14, 2015
Magellan Health Inc at JPMorgan Healthcare Conference - Q&A Session
Jan 14, 2015
Magellan Health Inc at JPMorgan Healthcare Conference
Dec 16, 2014
2015 Magellan Health Inc Guidance Call - Webcast
Nov 12, 2014
Magellan Health Inc at Barclays SMID Cap Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 2.79% 3.53%
Operating margin 2.70% 4.69%
EBITD margin - 6.72%
Return on average assets 5.25% 7.66%
Return on average equity 9.40% 11.52%
Employees 5,949 -
CDP Score - -


55 Nod Road
AVON, CT 06001
United States - Map
+1-410-9531000 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Magellan Health Inc. (Magellan), formerly Magellan Health Services, Inc., is engaged in the healthcare management business. The Company provides services to health plans, managed care organizations (MCOs), insurance companies, employers, labor unions, military and governmental agencies, third party administrators, and brokers. The Managed Healthcare business of the Company consists of management of behavioral healthcare services and the integrated management of physical and behavioral healthcare for special populations. The Specialty Solutions business consists of delivery of diagnostic imaging (radiology benefits management or RBM) and a variety of other specialty areas. The Pharmacy Management business comprises products and solutions that provide clinical and financial management of drugs paid under medical and pharmacy benefit programs.

Officers and directors

Barry M. Smith Chairman of the Board, Chief Executive Officer
Age: 60
Bio & Compensation  - Reuters
Tina Blasi Interim President - Magellan Pharmacy Solutions, Chief Executive Officer of National Imaging Associates, Inc.
Age: 56
Bio & Compensation  - Reuters
Robert W. Field Chief Executive Officer - Magellan Rx Management
Age: 66
Bio & Compensation  - Reuters
Sanjeev K. Srivastava Chief Executive Officer - Magellan Healthcare
Age: 46
Bio & Compensation  - Reuters
Caskie Lewis-Clapper Chief Human Resource Officer
Age: 49
Bio & Compensation  - Reuters
Renie Shapiro Senior Vice President, Corporate Finance
Bio & Compensation  - Reuters
Stewart J. Lavelle Chief Sales and Marketing Officer
Bio & Compensation  - Reuters
Daniel N. Gregoire General Counsel, Secretary
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Karen Amstutz Chief Medical Officer
Bio & Compensation  - Reuters
Robert M. Le Blanc Lead Independent Director
Age: 47
Bio & Compensation  - Reuters